MIRNA THERAPEUTICS 10-Q

Company

SYNLOGIC, INC.

Filed

August 4, 2017

Period of Report

June 30, 2017

Accession Number

0001527599-17-000018

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →